Table 1. The baseline characteristics and clinical outcome in MIS-C and Kawasaki- like MIS-C.
| Characteristic | Total(N = 225) | Kawasaki- like MIS-C | MIS-C | p-value |
|---|---|---|---|---|
| (n = 58) | (n = 167) | |||
| Age in month, median (IQR) | 55(26–96) | 56(32–89) | 54(24–96) | 0.94 |
| Gender, n (%) | ||||
| Male | 134(59.6) | 38(65.5) | 96(57.5) | 0.28 |
| Female | 91(40.4) | 20(34.5) | 71(42.5) | |
| Comorbid a | ||||
| Yes | 73(32.4) | 15(25.9) | 58(34.7) | 0.21 |
| No | 152(67.6) | 43(74.1) | 109(65.3) | |
| Type of comorbid a | ||||
| Obesity b | 44(24.9) | 7(14.3) | 37(28.9) | 0.04 |
| Seizures | 17(7.6) | 4(6.90) | 13(7.78) | 0.82 |
| Chronic lung disease | 12(5.33) | 5(8.62) | 7(4.19) | 0.19 |
| Immunosuppressive disorder malignancy | 3(1.33) | 0 | 3(1.80) | 0.57 |
| Type1 diabetes | 3(1.33) | 0 | 3(1.80) | 0.57 |
| G6PD insufficient | 16(7.11) | 5(8.62) | 11(6.59) | 0.60 |
| Hospital stay(days), median (IQR) | 9(7–13) | 9(7–12) | 9(7–13) | 0.82 |
| PICU admission | 129(57.3) | 33(56.9) | 96(57.5) | 0.93 |
| ICU stay(days), median (IQR) | 7(4–10) | 8(6–11) | 7(4–9.5) | 0.05 |
| Outcome | ||||
| Survived | 215(95·6) | 58(100) | 157(94.0) | 0.06 |
| Died | 10(4·44) | 0 | 10(5.99) |
a A patient may have at least one type of comorbid.
b The number of available patient height and weight information for calculating body mass was 177 patients.